Igenica Biotherapeutics is focused on the discovery of innovative antibody-based therapies for the treatment of cancer. Igenica’s integrated discovery engine has generated a novel pipeline of immunotherapies and ADCs that address the critical needs of cancer patients. Igenica is funded by a premier group of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
View Top Employees from Igenica Biotherapeutics, Inc.| Website | http://www.igenica.com |
| Revenue | $8.4 million |
| Funding | $58.1 million |
| Employees | 3 (1 on RocketReach) |
| Founded | 2009 |
| Address | 849 Mitten Rd. Ste. 104, Burlingame, California 94010, US |
| Phone | (650) 231-4320 |
| Industry | Biotechnology, Pharmaceuticals, Drug Discovery, Oncology, Science and Engineering, Antibodies, Healthcare, Life Science, Immune-oncology, Medical, Drug discovery, Health Care, Immunotherapies |
| Competitors | Cytovance Biologics, Oxford BioTherapeutics, Paragon Bioservices, Inc., PsiOxus |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Igenica Biotherapeutics, Inc. employee's phone or email?
Igenica Biotherapeutics, Inc. Questions
The Igenica Biotherapeutics, Inc. annual revenue was $8.4 million in 2023.
1 people are employed at Igenica Biotherapeutics, Inc..
Igenica Biotherapeutics, Inc. is based in Burlingame, California.
The NAICS codes for Igenica Biotherapeutics, Inc. are [32, 3254, 325].
The SIC codes for Igenica Biotherapeutics, Inc. are [283, 28].
Top Igenica Biotherapeutics, Inc. Employees
Related Companies
